Background {#Sec1}
==========

Migraine attacks may have different features with respect to different patients and also within the same patient. The percentage of patients reporting attacks as stereotyped and those reporting attacks with different phenotypes has not been the object of specific investigations. Here we wanted to evaluate the percentage of migraine patients reporting attacks with the same characteristics, in terms of phenotype and response to symptomatic medications, on three consecutive attacks.

Methods {#Sec2}
=======

Thirty patients with migraine without aura prospectively recorded the features of three consecutive attacks in a headache diary. Characteristics recorded were: pain intensity, presence of nausea, vomiting, photophobia, phonophophia, osmophobia, allodynia, cranial autonomic symptoms (at least one), and premonitory symptoms. Patients were allowed to take frovatriptan as symptomatic medication, whose efficacy was evaluated at the two hours pain-free rate.

Results {#Sec3}
=======

None of the patients presented identical characteristics on the three studied attacks (Table [1](#Tab1){ref-type="table"}). This was still the case if we reduced the number of variables evaluated from eleven to seven of the eight core features indicated by the ICHD. Considering just six variables: unilaterality, quality of pain, presence/absence of nausea, vomiting, photophobia and phonophobia, only two patients (6%) had identical features on three consecutive attacks.Table 1Migraine attack features and intrapatient variability.Unilateral locationPulsating qualityPain intensity (4 point scale)NVPTPNOACASPSNumber (%) of patients with three identical attacks with respect to some of the features recorded at the moment of symptomatic medication intake**xxxxxxxxxxx0 (0%)xxxxxxx0 (0%)xxxxxx2 (6%)xxxx9 (30%)xx10 (33%)**N: nausea, V: vomiting, PT: photophobia, PN: phonophobia; O: osmophobia; A: allodynia; CAS: cranial autonomic symptoms (at least one); PS: premonitory symptoms (at least one).

With respect to the response to frovatriptan, 39% of patients had the same outcome (positive or negative pain-free in 2 hours) on three consecutive attacks.

Conclusions {#Sec4}
===========

To the best of our knowledge this is the first study that systematically assessed the percentage of patients reporting migraine attacks with identical features in a given period. Our results demonstrate that migraine attacks show a high variability not just among patients, but also within the same patient. Our findings indicate that stereotype of attacks is uncommon, and reinforces the underlying logic of the current operational classification system.
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